Ticker: KPTI

Company: Karyopharm Therapeutics Inc.

Person: Kristin Abate, officer

Transaction date: Sept. 12, 2025

Reporting date: Sept. 16, 2025

Average share price: -6.43

Sold 23.0 shares for 147.89